All in the head: obstacles for immune rejection of brain tumours
Authors:
- 12 September 2002
- journal article
- review article
- Published by Wiley in Immunology
- Vol. 107 (1) , 28-38
Abstract
No abstract availableThis publication has 130 references indexed in Scilit:
- Fas ligand and the fate of antitumour cytotoxic T lymphocytesImmunology, 2002
- CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumorsInternational Journal of Cancer, 2002
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002
- FAS(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejectionInternational Journal of Cancer, 1999
- TRANSPLANTATION OF CD95 LIGAND-EXPRESSING GRAFTSTransplantation, 1997
- Fas and FasL in the homeostatic regulation of immune responsesImmunology Today, 1995
- Selective expression of interleukin-10 gene within glioblastoma multiformeBrain Research, 1994
- Nervous tissue as an immune compartment: the dialect of the immune response in the CNSImmunology Today, 1994
- Letter to the editorInternational Journal of Cancer, 1993
- Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patternsEuropean Journal of Cancer, 1993